Synthomer (LON:SYNT – Get Free Report) had its price target cut by equities researchers at Deutsche Bank Aktiengesellschaft from GBX 96 to GBX 62 in a research note issued to investors on Monday, MarketBeat.com reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential upside of 16.44% from the stock’s current price.
Separately, JPMorgan Chase & Co. decreased their target price on Synthomer from GBX 200 to GBX 120 and set a “neutral” rating for the company in a research report on Friday, October 10th. Four analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Synthomer has a consensus rating of “Hold” and a consensus target price of GBX 90.50.
View Our Latest Report on SYNT
Synthomer Stock Performance
Insider Activity
In related news, insider Michael Willome purchased 63,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The shares were purchased at an average price of GBX 49 per share, for a total transaction of £30,870. 5.03% of the stock is currently owned by corporate insiders.
About Synthomer
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
Read More
- Five stocks we like better than Synthomer
- Trump just signed it
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Refund From 1933: Trump’s Reset May Create Instant Wealth
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.
